Anatomical Therapeutic Chemical • J05AB11 • valaciclovir

J Antiinfectives for systemic use

J01 Antibacterials for systemic use

J02 Antimycotics for systemic use

J04 Antimycobacterials

J05 Antivirals for systemic use

J05A Direct acting antivirals

J05AA Thiosemicarbazones

J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors

J05AB01 acyclovir Indicated for: herpes virus infections

J05AB04 ribavirin Indicated for: chronic hepatitis C

J05AB06 ganciclovir Indicated for: cytomegalovirus infection

J05AB09 famciclovir Indicated for: herpes virus infections

J05AB11 valaciclovir Indicated for: herpes virus infections

J05AB12 cidofovir Indicated for: cytomegalovirus infection

J05AB14 valganciclovir Indicated for: cytomegalovirus infection

J05AB15 brivudine Indicated for: herpes zoster

J05AB16 remdesivir Indicated for: COVID-19

J05AB18 molnupiravir Indicated for: COVID-19

J05AB54 ribavirin + interferon alfa 2B Indicated for: chronic hepatitis C

J05AC Cyclic amines

J05AD Phosphonic acid derivatives

J05AE Protease inhibitors

J05AF Nucleoside and nucleotide reverse transcriptase inhibitors

J05AG Non-nucleoside reverse transcriptase inhibitors

J05AH Neuraminidase inhibitors

J05AJ Integrase inhibitors

J05AP Antivirals for treatment of HIV infections

J05AR Antivirals for treatment of HIV infections, combinations

J05AX Other antivirals

J06 Immune sera and immunoglobulins

J07 Vaccines